PMC:7228307 / 44412-44530
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 802 | 78-85 | Gene | denotes | FcγRIII | Gene:2214 | |
| 842 | 44-49 | Mutation | denotes | S239D | p.S239D | |
| 843 | 51-56 | Mutation | denotes | I332E | p.I332E |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T787 | 32-36 | http://purl.obolibrary.org/obo/CLO_0053432 | denotes | CD19 |
| T788 | 78-80 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes | pubann:has_HGVS_notation |
|---|---|---|---|---|---|---|
| 802 | 78-85 | Gene | denotes | FcγRIII | Gene:2214 | |
| 842 | 44-49 | Mutation | denotes | S239D | p.S239D | |
| 843 | 51-56 | Mutation | denotes | I332E | p.I332E |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T254 | 0-118 | Sentence | denotes | Tafasitamab (MOR208 XmAb 5574) CD19 IgG1 S239D; I332E Selectively enhance FcγRIII interaction Oncology Phase III |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T514 | 32-36 | Protein | denotes | CD19 | https://www.uniprot.org/uniprot/Q9BRD6|https://www.uniprot.org/uniprot/Q96S68|https://www.uniprot.org/uniprot/Q542B2|https://www.uniprot.org/uniprot/Q3LRP3|https://www.uniprot.org/uniprot/P25918|https://www.uniprot.org/uniprot/P25917|https://www.uniprot.org/uniprot/P15391|https://www.uniprot.org/uniprot/F5H635|https://www.uniprot.org/uniprot/A0N0P9 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T23 | 99-107 | Phenotype | denotes | Oncology | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T254 | 0-118 | Sentence | denotes | Tafasitamab (MOR208 XmAb 5574) CD19 IgG1 S239D; I332E Selectively enhance FcγRIII interaction Oncology Phase III |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T23 | 99-107 | Phenotype | denotes | Oncology | http://purl.obolibrary.org/obo/HP_0002664 |